Fig. 2From: Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled studyTotal WOMAC score (a), Mean VAS (b), Total LFI (c) in the UC-II, GC and placebo groups over the 180-day study period. Values are presented as mean ± SE. *Significant difference between the UC-II (n = 54) and the placebo (n = 53) group, p < 0.05. †Significant difference between the UC-II (n = 54) and the GC group (n = 57), p < 0.05Back to article page